Stephen G. Machatha's most recent trade in Aldeyra Therapeutics Inc was a trade of 22,073 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on Aug. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 5.15 per share. | 11 Aug 2025 | 22,073 | 221,799 (0%) | 0% | 5.2 | 113,713 | Common Stock |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 202,427 | 202,427 | - | - | Stock Option (right to buy) | |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.74 per share. | 12 Aug 2024 | 16,041 | 236,771 (0%) | 0% | 4.7 | 75,975 | Common Stock |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 12 Mar 2024 | 11,537 | 252,812 (0%) | 0% | 3.2 | 36,503 | Common Stock |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2024 | 405,450 | 405,450 | - | - | Stock Option (right to buy) | |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.41 per share. | 09 Mar 2024 | 18,231 | 255,032 (0%) | 0% | 3.4 | 62,102 | Common Stock |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 09 Mar 2024 | 11,537 | 243,495 (0%) | 0% | 3.2 | 36,503 | Common Stock |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 220,258 | 220,258 | - | - | Stock Option (right to buy) | |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 185,605 | 273,263 (0%) | 0% | 0 | Common Stock | |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 69,473 | 69,473 | - | - | Bonus Units | |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 116,201 | 116,201 | - | - | Employee Stock Option (Right to Buy) |